- The global companion animal health market was valued at $26.5 billion in 2025.
- Market revenue is projected to reach approximately $51.5 billion by 2032, growing at a CAGR of 9.9%.
- Rising pet ownership and the continued humanization of pets are fueling demand for veterinary healthcare products and services.
- Pharmaceuticals remain the largest market segment, while diagnostics are expected to see some of the fastest growth.
- North America currently leads the market, while Asia-Pacific is projected to experience the strongest expansion.
- Emerging technologies including AI, telemedicine, wearable monitoring devices, and precision medicine are reshaping veterinary care.
As pet owners continue to invest more heavily in preventive care and advanced treatment options, the global companion animal health market is expected to nearly double in value over the next seven years.
According to a new market analysis from Maximize Market Research, the companion animal health sector is forecast to grow from $26.48 billion in 2025 to nearly $51.48 billion by 2032, driven by increased pet ownership, expanding veterinary infrastructure, and ongoing innovation in animal healthcare.
Pet Ownership and Preventive Care Drive Growth
The report identifies growing pet adoption and the increasing humanization of pets as major forces behind market expansion. Dogs and cats continue to account for the largest share of veterinary healthcare spending as owners place greater emphasis on wellness, preventive medicine, and quality of life.
Routine vaccinations, diagnostic testing, parasite prevention, and nutritional management are becoming increasingly common components of companion animal healthcare, contributing to stronger demand for pharmaceuticals, vaccines, diagnostics, and veterinary services.
The report also notes that pet adoption trends accelerated during the COVID-19 pandemic and have continued to support long-term growth across the sector.
Technology Reshaping Veterinary Medicine
Technology is emerging as a key driver of market development.
Artificial intelligence, telemedicine platforms, wearable health monitoring devices, molecular diagnostics, and advanced imaging technologies are improving disease detection and treatment capabilities for veterinary professionals.
The adoption of cloud-based practice management software and remote consultation services is also helping improve access to care, particularly in underserved markets.
Meanwhile, pharmaceutical and biotechnology companies continue to invest in new therapies for chronic diseases, pain management, dermatologic conditions, and infectious diseases affecting companion animals.
Pharmaceuticals Lead, Diagnostics Gain Momentum
Pharmaceuticals currently represent the largest product category within the companion animal health market, supported by growing demand for anti-parasitics, anti-inflammatory medications, antibiotics, and pain management products.
Vaccines continue to benefit from increased awareness of disease prevention and concerns surrounding zoonotic disease transmission.
The diagnostics segment is expected to be among the fastest-growing areas of the market as veterinary practices adopt advanced laboratory testing, molecular diagnostics, and imaging technologies.
Regional Outlook
North America remains the largest regional market, supported by high pet ownership rates, established veterinary infrastructure, and strong consumer spending on animal healthcare.
Europe continues to maintain a significant share of the market, while Asia-Pacific is projected to experience the fastest growth through 2032. Rising disposable incomes, urbanization, and increased awareness of pet health are driving expansion across countries including China, India, Japan, and South Korea.
Looking Ahead
The report highlights several emerging opportunities that could further transform companion animal healthcare, including precision medicine, genetic testing, regenerative therapies, and connected health technologies.
Wearable devices capable of tracking activity levels, vital signs, and behavioral changes are expected to play an increasingly important role in preventive care and early disease detection. At the same time, advances in stem cell therapies and personalized treatment approaches could open new avenues for managing chronic and complex conditions in companion animals.
As investment continues to flow into diagnostics, pharmaceuticals, digital health, and veterinary infrastructure, the companion animal health sector is positioned for sustained growth throughout the remainder of the decade.
Information sourced from the company’s press release.
